Suppr超能文献

培养的上皮细胞(MDCK)转运功能的调控:鉴定一种与腺苷酸环化酶偶联的β-肾上腺素能受体。

Control of cultured epithelial (MDCK) cell transport function: identification of a beta-adrenoceptor coupled to adenylate cyclase.

作者信息

Rugg E L, Simmons N L

出版信息

Q J Exp Physiol. 1984 Apr;69(2):339-53. doi: 10.1113/expphysiol.1984.sp002810.

Abstract

A catecholamine-sensitive adenylate cyclase activity was observed in cell homogenates of cultured renal epithelial (MDCK) cells. 10 microM isoprenaline gave a 2.85-fold increase in adenylate cyclase activity above basal levels. A series of adrenoceptor agonists gave a relative potency series of isoprenaline greater than adrenaline greater than noradrenaline (K1(9) values of 1.9 X 10(-7), 1.6 X 10(-6) and 1.9 X 10(-5) M respectively), consistent with activation of a beta-adrenoceptor. Intracellular accumulation of cyclic AMP was also stimulated by 10 microM isoprenaline, peak values being observed after 2 min, followed by a decline to lower maintained levels. The phosphodiesterase inhibitor isobutylmethylzanthine (1 mM) augmented isoprenaline-stimulated cyclic AMP accumulation. In epithelial preparations of MDCK cells grown upon Millipore filters and mounted in Ussing chambers isoprenaline was only effective in elevating intracellular cyclic AMP contents when applied to the basal cell surfaces. Direct measurement of beta-adrenoceptor density and subtype was determined by (+/-)-3-[125I]iodocyanopindolol binding to MDCK cell homogenates. Binding consisted of a saturable component (Vmax = 14.9 fmol/mg cell protein) of high molar affinity (Kd = 10.8 pM) and a non-saturable component which showed a linear dependence on iodocyanopindolol concentration. In addition to the high-affinity binding site, dissociation kinetics revealed a low-affinity component (Kd = 450 pM) comprising 24% of saturable binding. Competition of (+/-)-3-[125I]iodocyanopindolol binding with beta-adrenoceptor agonists and antagonists was entirely consistent with the existence of a beta 2-adrenoceptor. Examination of various MDCK cultures and clones revealed the existence of MDCK cultures whose adenylate cyclase activity was unresponsive to catecholamine stimulation; this correlated with a reduced or undetectable level of (+/-)-3-[125I]iodocyanopindolol binding. The control of transepithelial chloride transport in MDCK epithelia by catecholamines is discussed.

摘要

在培养的肾上皮(MDCK)细胞的细胞匀浆中观察到一种对儿茶酚胺敏感的腺苷酸环化酶活性。10微摩尔异丙肾上腺素使腺苷酸环化酶活性比基础水平增加了2.85倍。一系列肾上腺素能受体激动剂给出的相对效价顺序为异丙肾上腺素大于肾上腺素大于去甲肾上腺素(K1(9)值分别为1.9×10(-7)、1.6×10(-6)和1.9×10(-5)M),这与β-肾上腺素能受体的激活一致。10微摩尔异丙肾上腺素也刺激了细胞内环磷酸腺苷(cAMP)的积累,在2分钟后观察到峰值,随后下降至较低的维持水平。磷酸二酯酶抑制剂异丁基甲基黄嘌呤(1毫摩尔)增强了异丙肾上腺素刺激的cAMP积累。在生长于微孔滤膜上并安装在尤斯灌流小室中的MDCK细胞的上皮制剂中,异丙肾上腺素仅在应用于基底细胞表面时才有效地提高细胞内cAMP含量。通过(±)-3-[125I]碘氰吲哚洛尔与MDCK细胞匀浆的结合来直接测定β-肾上腺素能受体密度和亚型。结合由高摩尔亲和力(Kd = 10.8皮摩尔)的可饱和成分(Vmax = 14.9飞摩尔/毫克细胞蛋白)和对碘氰吲哚洛尔浓度呈线性依赖的非可饱和成分组成。除了高亲和力结合位点外,解离动力学显示存在一个低亲和力成分(Kd = 450皮摩尔),占可饱和结合的24%。(±)-3-[125I]碘氰吲哚洛尔与β-肾上腺素能受体激动剂和拮抗剂的结合竞争完全与β2-肾上腺素能受体的存在一致。对各种MDCK培养物和克隆的检查揭示了存在一些MDCK培养物,其腺苷酸环化酶活性对儿茶酚胺刺激无反应;这与(±)-3-[125I]碘氰吲哚洛尔结合水平降低或无法检测相关。讨论了儿茶酚胺对MDCK上皮细胞跨上皮氯转运的控制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验